Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-15

Clinical Trial Update: Brain Energy and Aging With Triheptanoin [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for triheptanoin in frontal lobe hypometabolism; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triheptanoin (triheptanoin)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Frontal Lobe Hypometabolism | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-04-15